These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15599118)

  • 1. Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade.
    Weber M; Basile J; Izzo J; Oparil S
    J Clin Hypertens (Greenwich); 2004 Dec; 6(12):699-705. PubMed ID: 15599118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where are we going? Beyond JNC 7.
    Giles TD; Oparil S; Pickering TG
    Prev Cardiol; 2007; 10(4):222-7. PubMed ID: 17917520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes.
    Andros V; Egger A; Dua U
    J Manag Care Pharm; 2006 May; 12(4):303-9. PubMed ID: 16792436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the management of hypertension: recent clinical trials and the JNC 7.
    Moser M
    J Clin Hypertens (Greenwich); 2004 Oct; 6(10 Suppl 2):4-13. PubMed ID: 15470293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ALLHAT study revisited: do newer data from this trial and others indicate changes in treatment guidelines?
    Moser M; Oparil S; Cushman W; Papademetriou V
    J Clin Hypertens (Greenwich); 2007 May; 9(5):372-80. PubMed ID: 17485973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the risk of stroke through appropriate targets and treatments.
    Davidson MH; Basile J; Garber AJ; Phillips RA
    Prev Cardiol; 2007; 10(4):215-21. PubMed ID: 17917519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension, renal disease, and cardiovascular outcomes.
    Moser M; Basile J; Cushman W
    J Clin Hypertens (Greenwich); 2005 Aug; 7(8):479-84. PubMed ID: 16103759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive emergencies.
    Moser M; Izzo JL; Bisognano J
    J Clin Hypertens (Greenwich); 2006 Apr; 8(4):275-81. PubMed ID: 16596031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roundtable discussion: hypertension in children and adolescents.
    Moser M; Giles TD; Falkner B; Schwartz AB; Townsend RR
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):24-30. PubMed ID: 15655383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations.
    Kelly MS; Saseen JJ; Marrs JC
    Ther Adv Cardiovasc Dis; 2017 Feb; 11(2):63-71. PubMed ID: 28033742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: Strengths and limitations of the JNC 8 hypertension guidelines.
    Mancia G
    Nat Rev Cardiol; 2014 Apr; 11(4):189-90. PubMed ID: 24514021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicting and confusing data from the hypertension treatment trials: whom and what should you believe?
    Moser M; Giles T; Oparil S
    J Clin Hypertens (Greenwich); 2005 Jul; 7(7):403-8. PubMed ID: 16015050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.
    Hyman DJ; Pavlik VN
    Arch Intern Med; 2000 Aug 14-28; 160(15):2281-6. PubMed ID: 10927724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
    Ichikawa S; Takayama Y
    Hypertens Res; 2001 Nov; 24(6):641-6. PubMed ID: 11768722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrochlorothiazide versus calcium channel blockers: what is the best add-on to a renin-angiotensin system blocker for treating hypertension in patients with renal disease?
    Lerma EV
    Curr Hypertens Rep; 2011 Oct; 13(5):386-95. PubMed ID: 21796332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond JNC 8: implications for evaluation and management of hypertension in underserved populations.
    Burns J; Persaud-Sharma D; Green D
    Acta Cardiol; 2019 Feb; 74(1):1-8. PubMed ID: 29504458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year.
    Alderman MH; Madhavan S; Cohen H
    Am J Hypertens; 1996 May; 9(5):413-8. PubMed ID: 8735170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Borden WB; Maddox TM; Tang F; Rumsfeld JS; Oetgen WJ; Mullen JB; Spinler SA; Peterson ED; Masoudi FA
    J Am Coll Cardiol; 2014 Dec; 64(21):2196-203. PubMed ID: 25447261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.